---
title: "Special Controls, Definition | MedTech Terms"
description: "Device-type-specific FDA requirements (often performance standards, labeling, or post-market surveillance) that apply on top of General Controls."
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/special-controls#term",
        "name": "Special Controls",
        "description": "Special Controls are mandatory for Class II devices and are usually documented in a device-specific classification regulation or Special Controls guidance. They commonly require specific bench testing, biocompatibility, software documentation levels, or labeling statements.",
        "url": "https://medtechterms.com/terms/special-controls",
        "termCode": "special-controls",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/special-controls#article",
        "headline": "Special Controls",
        "description": "Device-type-specific FDA requirements (often performance standards, labeling, or post-market surveillance) that apply on top of General Controls.",
        "url": "https://medtechterms.com/terms/special-controls",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/special-controls"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/special-controls#term"
        },
        "articleSection": "Regulatory",
        "inLanguage": "en",
        "keywords": "Special Controls, Regulatory, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "IMDRF Documents",
            "url": "https://www.imdrf.org/documents",
            "publisher": {
              "@type": "Organization",
              "name": "IMDRF"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "RAPS Regulatory Focus",
            "url": "https://www.raps.org/news-and-articles/news-articles",
            "publisher": {
              "@type": "Organization",
              "name": "RAPS"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "FDA - Medical Devices",
            "url": "https://www.fda.gov/medical-devices",
            "publisher": {
              "@type": "Organization",
              "name": "FDA"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/general-controls#term",
            "name": "General Controls",
            "url": "https://medtechterms.com/terms/general-controls"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/510k#term",
            "name": "510(k) Premarket Notification",
            "alternateName": "510(k)",
            "url": "https://medtechterms.com/terms/510k"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Regulatory",
            "item": "https://medtechterms.com/terms?cat=Regulatory"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Special Controls",
            "item": "https://medtechterms.com/terms/special-controls"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/special-controls#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "What is the primary purpose of Special Controls?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "The primary purpose is to provide specific, device-related requirements beyond General Controls to help ensure the safety and effectiveness of Class II devices."
            }
          },
          {
            "@type": "Question",
            "name": "Where can one find Special Controls for a particular device?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Special Controls are typically found in the device-specific classification regulation (e.g., in 21 CFR Parts 862-892) or in FDA guidance documents specifically issued for certain device types."
            }
          },
          {
            "@type": "Question",
            "name": "Do Special Controls always involve testing requirements?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "While often including testing, such as bench testing or biocompatibility, Special Controls can also mandate specific labeling, software documentation, or other performance standards tailored to the device's risks."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Regulatory](/terms?cat=Regulatory)
6.  /
7.  Special Controls

[All terms](/terms)

Regulatory [Regulated Pathways](/ecosystems/regulated-pathways)[Post-Market & Safety](/ecosystems/post-market-safety)[Global Markets](/ecosystems/global-markets)

# Special Controls

Device-type-specific FDA requirements (often performance standards, labeling, or post-market surveillance) that apply on top of General Controls.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

Special Controls are mandatory for Class II devices and are usually documented in a device-specific classification regulation or Special Controls guidance. They commonly require specific bench testing,  [biocompatibility](/terms/biocompatibility), software documentation levels, or  [labeling](/terms/labeling) statements. 

What the regulation says

The FDA applies Special Controls to Class II medical devices to provide reasonable assurance of their safety and effectiveness. These controls often supplement  [General Controls](/terms/general-controls) and are outlined in device-specific classification regulations, as per 21 CFR Part 860, Subpart C, or in Special Controls guidance documents. 

## What this means in practice

Mapping a 510(k) to its product code's Special Controls early prevents late-stage scope surprises and forms the basis of the testing plan. 

## Examples

-   A manufacturer of a new Class II infusion pump must adhere to Special Controls that specify performance testing for accuracy and alarm functionality, in addition to general quality system requirements.
-   For a Class II continuous glucose monitor, Special Controls may require specific clinical accuracy studies and detailed cybersecurity documentation for its wireless communication features.
-   A company developing a Class II surgical mesh needs to ensure their product meets Special Controls related to biocompatibility testing and labeling for potential adverse tissue reactions.

Common pitfalls

-   • Failing to identify all applicable Special Controls early in the device development process can lead to significant delays and redesigns. 
-   • Misinterpreting the scope or requirements of a Special Control can result in non-compliant submissions and regulatory hurdles. 
-   • Assuming that General Controls alone are sufficient for a Class II device, neglecting the additional requirements imposed by Special Controls, is a common error. 

## Frequently asked questions

What is the primary purpose of Special Controls? 

The primary purpose is to provide specific, device-related requirements beyond  [General Controls](/terms/general-controls) to help ensure the safety and effectiveness of Class II devices. 

Where can one find Special Controls for a particular device? 

Do Special Controls always involve testing requirements? 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Regulatory

510(k) Premarket Notification(510(k)) 

FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.





](/terms/510k)[

Regulatory

General Controls

Baseline FDA requirements that apply to all medical devices regardless of class.





](/terms/general-controls)

### More in Regulatory

· Same category 

[

Regulatory

510(k) Summary vs 510(k) Statement

Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.





](/terms/510k-summary-vs-statement)[

Regulatory

513(g) Request for Information(513(g)) 

Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.





](/terms/513g)[

Regulatory

Abbreviated 510(k)

510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.





](/terms/abbreviated-510k)[

Regulatory

Accreditation Scheme for Conformity Assessment(ASCA) 

FDA voluntary program in which accredited testing labs perform standards-based testing accepted with reduced FDA scrutiny.





](/terms/asca)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (3)

-   [Regulated Pathways](/ecosystems/regulated-pathways)
-   [Post-Market & Safety](/ecosystems/post-market-safety)
-   [Global Markets](/ecosystems/global-markets)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

IMDRF· 1 RAPS· 1 FDA· 1 

1.  [1 
    
    IMDRF Documents
    
    Verified 
    
    IMDRF · imdrf.org 
    
    
    
    ](https://www.imdrf.org/documents)
2.  [2 
    
    RAPS Regulatory Focus
    
    Verified 
    
    RAPS · raps.org 
    
    
    
    ](https://www.raps.org/news-and-articles/news-articles)
3.  [3 
    
    FDA - Medical Devices
    
    Verified 
    
    FDA · fda.gov 
    
    
    
    ](https://www.fda.gov/medical-devices)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Navigating an FDA or EU MDR submission?

Blue Goat Cyber supports the cybersecurity content of premarket submissions, from threat models to the 524B narrative.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Regulatory

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=special-controls)

Learn in 60 seconds

Card Lesson Quiz

Device-type-specific FDA requirements (often performance standards, labeling, or post-market surveillance) that apply on top of General Controls.

-   · Mapping a 510(k) to its product code's Special Controls early prevents late-stage scope surprises and forms the basis of the testing plan. 
-   · They commonly require specific bench testing, biocompatibility, software documentation levels, or labeling statements. 

Remember this

Watch out: Failing to identify all applicable Special Controls early in the device development process can lead to significant delays and redesigns.

Related terms

-   [General Controls ](/terms/general-controls)
-   [510(k) Premarket Notification(510(k)) ](/terms/510k)

You may also need

Auto-suggested from Regulatory and shared keywords.

-   [Common Specifications (IVDR)(CS) ](/terms/ivdr-common-specifications)
-   [General Safety and Performance Requirements (IVDR)(GSPR) ](/terms/ivdr-gspr)
-   [Post-Market Surveillance Plan (IVDR) ](/terms/ivdr-pms-plan)
-   [De Novo Classification Request(De Novo) ](/terms/de-novo)
-   [AI Act Technical Documentation (Annex IV) ](/terms/ai-act-technical-documentation)
-   [CE Mark ](/terms/ce-mark)

[All Regulatory terms](/terms?cat=Regulatory)

From the Blue Goat network

Related resources and services on this topic.

-   [
    
    MedTech Cybersecurity Standards 
    
    Authoritative reference for the standards and guidances behind medical device cybersecurity.
    
    ](https://medtechcyberstandards.com)
-   [
    
    MedTech Cybersecurity Crosswalk 
    
    International crosswalk of medical device cybersecurity requirements across regulators.
    
    ](https://mdccrosswalk.com)
-   [
    
    MedTech Truths 
    
    Common misconceptions about medical device development - debunked.
    
    ](https://mdcmisconceptions.com)
-   [
    
    MedTech Launchpad 
    
    MedTech funding rounds, accelerators, and launch resources.
    
    ](https://medtechlaunchguide.com)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)